Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas”
1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12275781
Monoclonal antibodies against MHC-bound human dickkopf-1 peptides and uses thereof
granted -
US 12274725
Zika virus strains for treatment of glioma
granted -
US 12263243
Templated open flocs of anisotropic particles for enhanced pulmonary delivery
granted -
US 12263165
Small molecule inhibitors of cancer stem cells and mesenchymal cancer types
granted -
US 12257262
Method of reconstituting liposomal annamycin
granted -
US 12257261
Preparation of preliposomal Annamycin lyophilizate
granted -
US 12252464
Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids
granted -
US 12252480
Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide
granted -
US 12251449
Synthetic multidomain peptide biomaterials that inhibit inducible nitric oxide synthase
granted -
US 12247206
Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancer
granted -
US 12246057
Transmembrane stem cell factor (tm-SCF) lipid nanocarriers and methods of use thereof
granted -
US 12234516
Biomarkers of response to HIF-2-alpha inhibition in cancer and methods for the use thereof
granted -
US 12226404
Methods for making compositions for pulmonary administration
granted -
US 12215162
BAFF-R targeted chimeric antigen receptor-modified T-cells and uses thereof
granted -
US 12209240
Antisense antibacterial compounds and methods
granted -
US 12202877
T cell receptors with mage-B2 specificity and uses thereof
granted -
US 12201700
Micro- and nano-device for cartilage injury detection and treatment
granted -
US 12202895
LILRB4 antibodies and uses thereof
granted -
US 12201684
Compositions for stimulation of mammalian innate immune resistance to pathogens
granted -
US 12195804
Treatment of squamous cell carcinoma
granted -
US 12194059
Compositions comprising citrate and applications thereof
granted -
US 12187799
Dual specificity antibodies to PD-L1 and PD-L2 and methods of use therefor
granted -
US 12186324
Imidazopiperazine inhibitors of transcription activating proteins
granted -
US 12188039
Recombinant adeno-associated viral vector for gene delivery
granted